Last quarter (Q2 2025), BioStem Technologies's total revenue was $49.30M, a decrease of -33.82% from the same quarter last year. In Q2, BioStem Technologies's net income was $-564.36K. See BioStem Technologies’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 301.83M	$ 16.69M	$ 6.88M	$ 4.34M	$ 2.52M
Gross Profit	$ 287.86M	$ 15.42M	$ 5.99M	$ 2.87M	$ 1.25M
Operating Expenses	$ 256.66M	$ 23.20M	$ 10.67M	$ 4.47M	$ 3.09M
Depreciation and Amortization	$ 293.22K	$ 229.02K	$ 243.42K	$ 283.90K	$ 268.58K
EBITDA	$ 31.49M	$ -7.55M	$ -6.52M	$ -602.00K	$ -2.25M
Operating Income	$ 31.20M	$ -7.78M	$ -4.68M	$ -1.61M	$ -1.84M
Other Income/Expenses	$ -587.22K	$ -704.01K	$ -2.55M	$ 193.93K	$ -526.97K
Pretax Income	$ 30.61M	$ -8.48M	$ -7.11M	$ -1.41M	$ -2.37M
Net Income	$ 31.88M	$ -8.48M	$ -7.07M	$ -1.45M	$ -2.39M
Per Share Metrics
Basic EPS	$ 1.95	$ -0.62	$ -0.62	$ -0.12	$ -0.26
Diluted EPS	$ 1.47	$ -0.62	$ -0.62	$ -0.12	$ -0.26
Weighted Average Shares Outstanding	16.37M	13.71M	11.41M	11.69M	9.18M
Weighted Average Shares Outstanding (Diluted)	21.70M	13.71M	11.41M	11.69M	9.18M

Currency in USD

BioStem Technologies Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing